I’m a dude, 55 a week ago, been in the game since 2012. I have gained about 300% in a cash account lost 50% in a margin account (mostly due to ill-advised short positions). It just seemed rude not to say something as everyone was demasking. Nice diversity of age, how about gender?
I made some $$ in Ariad as a late-comer and followed the crowd from ARRY to AUPH. My concern with AUPH is the single drug pipeline and only in phase II. I am optimistically cautious because this could take more than two years. I am still in ARRY that has several drugs in the pipeline already in phase III with partners. This bunch dropped the stock after “Denner jumped ship.” So far, I’m losing $$ on both ARRY & AUPH.
Does anyone expect significant price appreciation in AUPH before 2019?
News 
Market Data 
Discover 
